Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

Experimental Medicine and Rheumatology awarded European Centre of Excellence status

The Centre for Experimental Medicine and Rheumatology (EMR) at Queen Mary University of London has been honoured with the highly prestigious EULAR Centre of Excellence award in recognition of its outstanding contributions to the field of rheumatology and dedication to improving patient care.

Images of EULAR plaque, Prof Costantino Pitzalis, Prof Amrita Ahluwalia, and researchers from teh Centre for Experimental Medicine and Rheumatology at Queen Mary University of London. .

Clockwise from top-left: EULAR plaque, Prof Costantino Pitzalis (Head of EMR) and Prof Amrita Ahluwalia (FMD Dean for Research), the unveiling of the EULAR plaque, and members of EMR. 

The five year status (2023-2028) recognises EMR as one of the top research centres for rheumatology in Europe and was awarded based on the centre’s integrated, multidisciplinary research team of Clinicians, Scientists, Biostatisticians, Bioinformaticians, Clinical Trial Managers and administrative support staff who strive to deliver best care to patients with Rheumatic Diseases.

The European Alliance of Associations for Rheumatology (EULAR) represents and collaborates with national rheumatology associations throughout Europe. This network plays a pivotal role in advancing rheumatology knowledge and enhancing the well-being of patients across the continent.

Thanks to invaluable resources provided by the National Institute for Health and Care Research (NIHR) Barts Biomedical Research Centre (BRC), EMR has been empowered to create a truly exceptional centre of excellence and establish itself as an internationally recognised leader in rheumatology research.

Professor Costantino Pitzalis, Head of EMR, said: “We are deeply honoured to receive this award. This recognition highlights the collaborative efforts of dedicated researchers, clinicians, and patients within our centre who are united in advancing our understanding of rheumatic diseases and transform current practice through a precision medicine approach.”



Back to top